Interpace Biosciences Valuation
| IDXGDelisted Stock | USD 2.20 0.00 0.00% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Interpace Biosciences retains a regular Real Value of $1.74 per share. The prevalent price of the firm is $2.2. Our model calculates the value of Interpace Biosciences from evaluating the firm fundamentals such as Return On Asset of -0.26, current valuation of 11.72 M, and Return On Equity of -2.85 as well as inspecting its technical indicators and probability of bankruptcy. . In general, most investors encourage locking in undervalued assets and disposing overvalued assets since, at some point, asset prices and their ongoing real values will come together.
Overvalued
Today
Please note that Interpace Biosciences' price fluctuation is very steady at this time. Calculation of the real value of Interpace Biosciences is based on 3 months time horizon. Increasing Interpace Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Interpace otc stock is determined by what a typical buyer is willing to pay for full or partial control of Interpace Biosciences. Since Interpace Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Interpace OTC Stock. However, Interpace Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.2 | Real 1.74 | Hype 2.2 | Naive 1.59 |
The real value of Interpace OTC Stock, also known as its intrinsic value, is the underlying worth of Interpace Biosciences OTC Stock, which is reflected in its stock price. It is based on Interpace Biosciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Interpace Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Interpace Biosciences helps investors to forecast how Interpace otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Interpace Biosciences more accurately as focusing exclusively on Interpace Biosciences' fundamentals will not take into account other important factors: Interpace Biosciences Total Value Analysis
Interpace Biosciences is currently anticipated to have valuation of 11.72 M with market capitalization of 5.16 M, debt of 9.44 M, and cash on hands of 1.86 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Interpace Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.72 M | 5.16 M | 9.44 M | 1.86 M |
Interpace Biosciences Investor Information
About 28.0% of the company shares are held by company insiders. The company recorded a loss per share of 3.12. Interpace Biosciences last dividend was issued on the 15th of January 2020. The entity had 1:10 split on the 15th of January 2020. Based on the key indicators related to Interpace Biosciences' liquidity, profitability, solvency, and operating efficiency, Interpace Biosciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Interpace Biosciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Interpace Biosciences has an asset utilization ratio of 107.51 percent. This implies that the OTC Stock is making $1.08 for each dollar of assets. An increasing asset utilization means that Interpace Biosciences is more efficient with each dollar of assets it utilizes for everyday operations.Interpace Biosciences Ownership Allocation
Interpace Biosciences secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.Interpace Biosciences Profitability Analysis
The company reported the previous year's revenue of 41.31 M. Net Loss for the year was (14.94 M) with profit before overhead, payroll, taxes, and interest of 17.95 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Interpace Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Interpace Biosciences and how it compares across the competition.
About Interpace Biosciences Valuation
The otc valuation mechanism determines Interpace Biosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Interpace Biosciences. We calculate exposure to Interpace Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Interpace Biosciences's related companies.Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey. Interpace Diag operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 147 people.
8 Steps to conduct Interpace Biosciences' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Interpace Biosciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Interpace Biosciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Interpace Biosciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Interpace Biosciences' revenue streams: Identify Interpace Biosciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Interpace Biosciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Interpace Biosciences' growth potential: Evaluate Interpace Biosciences' management, business model, and growth potential.
- Determine Interpace Biosciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Interpace Biosciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Interpace Biosciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Interpace Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 4.2 M | |
| Retained Earnings | -227.1 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Interpace OTC Stock
If you are still planning to invest in Interpace Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Interpace Biosciences' history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |